Founded in 2020 by Dr. Biju Jacob and Neeraj Kumar, Healium Intelliscan develops AI-integrated ultrasound technology for early detection and management of chronic kidney disease. Its system combines renal ultrasound imaging with digital biomarkers and predictive analysis, including patient-specific perfusion modeling to help identify CKD and its possible causes. The company submitted its device for FDA 510(k) clearance in 2024; clearance is pending.
FDA 510(k) clearance pending
Compliance program
SwiftSoundBuilt by a radiology resident and former Philips Ultrasound engineers, SwiftSound develops physical-AI ultrasound systems for imaging and real-time 3D needle guidance. Its compact cart and smart probes are designed to work with standard needles and existing procedural workflows, with a beta prototype combining B-mode imaging and needle tracking. The Washington, D.C.-based company is at the pre-seed stage, with a patent filed and an FDA 510(k) pathway identified; its system remains investigational and is not cleared for clinical use.WASHINGTON, DC
Chloros Medical LLCChloros Medical LLC is developing technology for disinfecting ultrasound probes. Its technology is in development and is not yet FDA cleared for use.
Lumenate MedicalLumenate Medical is developing a catheter-based cystoscope that lets non-urologist providers collect bladder images for remote review by board-certified urologists. Founded by a team that includes Johns Hopkins engineering and medical expertise, the Baltimore-based company is focused on shortening long waits for bladder cancer screening while keeping specialists in the decision-making loop. Its device remains in development and is not yet cleared or approved for sale by the U.S. Food and Drug Administration.
Kilele Health IncFounded by medtech veterans Andrew Cothrel and Jason Heikenfeld, Kilele Health is an Oakwood startup developing tools to bring continuous biochemical insight into care beyond the clinic. Its SunVida™ platform is intended to help patients and care teams manage chronic conditions with more timely molecular data.